Skip to content


If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Latest BioAlps news

Ibex™ Lonza facilit in Visp Switzerland

Lonza invested CHF 1 billion in Visp in 2022

The biopharmaceutical company employs 5,000 people in Valais, and also announced a 15% sales growth in 2022, representing a total…

Alithea Chuv Pamgene

CHUV, Alithea Genomics and PanGene partner to develop a pan-cancer blood test

The three partners secured a €1 million ($1.1 million) in Eurostars grant funding to develop a first of a king…

Magali Bischof Labiotech

BioAlps and the Swiss Health Valley

Listen to Magali Bischof, BioAlps Secretary General, on Beyond Biotech podcast speaking about the Swiss Health Valley and the role…

Chuv, Ludwig Institute, EPFL

CHUV, EPFL, SIB and Roche found molecules able to suppress resistance to immunotherapy

A breakthrough in the fight against cancer: researchers from EPFL, the Ludwig Institute of the CHUV, the SIB, and Roche…

HUG Center Virtual Medicine

The HUG open a Centre for Virtual Medicine

The new Centre for Virtual Medicine at the HUG is a pioneer in the use of virtual reality for clinical…


BIONOMOUS closes a USD 2.7 million Series A

The Swiss-based startup builds devices to automate processes in Life Science research and prepares a product rollout and expansion.  …


Virtual reality glasses used as a diagnostic tool for brain disorders

MachineMD, a spin-off of Inselspital Bern, and CSEM, are collaborating to diagnose brain diseases by analyzing eye movements with a…

Neurosoft Bioelectronics

Neurosoft Bioelectronics receives ISO Certification for its Quality Management System

Neurosoft Bioelectronics SA, a startup developing implantable brain-computer interfaces, announces that it has received ISO 13485:2016 Certification by TÜV SÜD…


A CHF 1 billion contract for Bachem Group

The contract covers the delivery of a large volume of peptides over a five-year period from 2025-2029, and follows the…

MPC Therapeutics

A CHF 1.5M seed-funding round for MPC Therapeutics to improve CAR-T cancer therapies

MPC Therapeutics (MPC Tx), is a Swiss biotechnology company based in Geneva, focusing on metabolism and cellular rejuvenation.   The…

ten23 health

Swissfillon becomes ten23 health

ten23 health®, a global contract development and manufacturing organization (CDMO) announces the change in branding of its in Visp, Switzerland…


STALICLA signs exclusive in-licensing agreement with Novartis for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment

The transaction with Novartis reinforces STALICLA’s position as the leading developer of precision medicines for neurodevelopmental disorders and heralds the…

Latest Republic of Innovation news

Loading RSS Feed